Evotec OAI Extends Medicinal Chemistry Agreement with Avidex
Hamburg, Germany, December 6, 2002
Hamburg, Germany | Abingdon, UK - Evotec OAI AG (NM: EVT), a partner for integrated high-value-added drug discovery services to the pharmaceutical and biotechnology industries, announced today that it has signed an extension to ...
Evotec OAI: Direvo Raises EUR 10.5 Million in Series B Financing
Hamburg, Germany, November 26, 2002
Hamburg, Germany | Abingdon, UK - Evotec OAI AG (NM: EVT), a partner for integrated high-value-added drug discovery services to the pharmaceutical and biotechnology industries, announced today that Direvo Biotech AG has raised ...
Evotec OAI Enters into Innovative Drug Discovery and Development Agreement with Venture Capital Firm Oxford Bioscience Partners
Hamburg, Germany, November 14, 2002
Download PDFHamburg, Germany | Abingdon, UK | Boston, USA - Evotec OAI AG, Hamburg, Germany (NM: EVT), a partner for integrated high-value-added drug discovery services to the pharmaceutical and biotechnology industries, and ...
Evotec OAI Announces Update on Annual Guidance
Hamburg, Germany, October 23, 2002
Hamburg, Germany | Abingdon, UK - Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT) announces third quarter revenues and an update on the company's forecast for its 2002 financial performance. "Based on our excellent ...
Evotec Technologies Launches High-Throughput Cell Analyser 'Opera'
Hamburg, Germany, October 10, 2002
Revolution in high-content analysis of cellular events in assay development and screening
Hamburg, Germany - Evotec Technologies GmbH, Hamburg, Germany, a wholly-owned subsidiary of Evotec OAI AG (Neuer Markt: EVT) providing ...
Evotec OAI Grants Licence to Roche Diagnostics
Hamburg, Germany, August 22, 2002
Hamburg, Germany | Abingdon, UK - Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a partner for integrated high-value-added drug discovery to the pharmaceutical and biotechnology industries, today announced that it granted a ...
Second Quarter 2002: Evotec OAI Meeting its Growth Targets
Hamburg, Germany, August 20, 2002
Sales increase of 26% to EUR 33.2 million, in line with company guidance
Net loss reduced by 82% to EUR (13.7) million
EBITDA improved by 28%
Cash burn significantly reduced year-on-year
Strong order book ...
Infinity Pharmaceuticals Selects Evotec OAI as Their Assay Development and Screening Partner
Hamburg, Germany, June 13, 2002
Hamburg, Germany | Abingdon, UK | Boston, USA - Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a partner for integrated high-value-added drug discovery to the pharmaceutical and biotechnology industries, announced today the ...
Evotec OAI and Taisho Pharmaceutical Co., Ltd. Start Drug Discovery Collaboration
Hamburg, Germany, May 22, 2002
Hamburg, Germany | Abingdon, UK | Tokyo, Japan - Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a supplier of integrated high value added drug discovery services, announced today that it has entered into a drug discovery ...
Evotec OAI Signs Contract Extension with Vertex Pharmaceuticals
Hamburg, Germany, May 15, 2002
Download PDFHamburg, Germany | Abingdon, UK - Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a supplier of integrated high value added drug discovery services, announced today that it will continue to provide drug discovery ...
Evotec OAI and Novartis intensify collaboration
Hamburg, Germany, May 8, 2002
Hamburg, Germany | Abingdon, UK - Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a supplier of integrated high value added drug discovery services, announced today that its long-term partner Novartis will acquire additional ...
Roche extends Discovery Chemistry Agreement with Evotec OAI
Hamburg, Germany, April 29, 2002
Hamburg, Germany | Abingdon, UK - Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a supplier of integrated high value added drug discovery services, announced today the extension of its original one-year discovery chemistry ...
Evotec OAI and SiREEN Enter Into A Drug Discovery and Development Agreement To Identify New Small Molecule Therapeutics
Hamburg, Germany, March 25, 2002
Hamburg, Germany | Abingdon, UK | Munich, Germany - Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a supplier of integrated high value added drug discovery services, and SiREEN AG, a drug discovery and development company, ...
Evotec OAI and Ionix Collaborate on Analgesic Drug Discovery
Hamburg, Germany, February 5, 2002
Hamburg, Germany | Abingdon, UK " Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a supplier of integrated high-value-added drug discovery services, announced today that it has signed an agreement with Ionix ...
Evotec OAI and Serono Extend Discovery Chemistry Agreement First compounds resulting from the collaboration progressing into pre-clinical testing.
Hamburg, Germany, January 24, 2002
Hamburg, Germany/ Abingdon, UK " Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a supplier of integrated high-value-added drug discovery services, announced today a one year, EUR 2.4 million lead optimisation programme ...